Tables and figures
View the most recent version.
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
Table 1
Parameter estimates related to efficacy of low-dose computed tomography screening
Table 2
Calibration parameters to adjust baseline survival of screen-detected non-small-cell cancers to match stage-specific survival curves and reported mortality reductions in National Lung Screening Trial (NLST)
Table 3
Incremental lung cancer-specific survival between low-dose computed tomography screening and control arm, by stage and years survived from diagnosis of non-small-cell lung cancer, Cancer Risk Management Model-Lung Cancer (CRMM-LC) and National Lung Screening Trial (NLST)
Table 4
Cumulative number of lung cancer deaths and percent mortality reduction due to low-dose computed tomography screening, by study year, Cancer Risk Management Model-Lung Cancer (CRMM-LC) screening model and National Lung Screening Trial (NLST)
Table 5
Selected screening program scenarios, Cancer Risk Management Model-Lung Cancer (CRMM-LC) and Cancer Intervention and Surveillance Modeling Network (CISNET)
Figure 1
Number of new lung cancer cases, by screen arm and study year, Cancer Risk Management Model-Lung Cancer (CRMM-LC) screening model and National Lung Screening Trial (NLST)
Figure 2
Cumulative number of new lung cancer cases, by screen arm and study year, Cancer Risk Management Model-Lung Cancer (CRMM-LC) screening model and National Lung Screening Trial (NLST)
